Nordic Life Sciences A/S
CVR 41727659 · Public limited company (A/S) · Active · Very high risk
Nordic Life Sciences A/S is a Public limited company (A/S), founded on , based in Søndersø. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 9.4% over the next 12 months, which is 6.7 times the average for Danish companies. 5 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (30 Jun 2025) shows equity of DKK -13.9m and a net result of DKK -9.3m. CEO: Erik Sundt.
Bankruptcy risk for Nordic Life Sciences A/S
6.7 × the average (1.41%) · higher risk than 97% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41727659
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (6 years)
- Address
- Langehede 103A
5471 Søndersø - Municipality
- Nordfyns
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 467k
- Auditor
- Beierholm
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 4 of 5 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -208.1% |
| Current ratio | 31% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -8.9m | DKK -10.3m |
| Net profit | DKK -9.3m | DKK -11.1m |
| Equity | DKK -13.9m | DKK -20.0m |
| Total assets | DKK 6.7m | DKK 7.1m |
| Cash | DKK 281k | – |
| Short-term debt | DKK 20.6m | – |
| Avg. employees | 4 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 218 | Late | |
| 1 Jul 2023 – 30 Jun 2024 | 218 | Late | |
| 1 Jul 2022 – 30 Jun 2023 | 162 | ||
| 1 Jul 2021 – 30 Jun 2022 | 213 | Late | |
| 24 Sep 2020 – 30 Jun 2021 | 188 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Erik Sundt | Current | |
| CEO | Pål Anders Nordvi | ||
| CEO | Anders Raft | ||
| Board | Erik Sundt | Current | |
| Board | Pål Anders Nordvi | Current | |
| Board | Anders Raft | ||
| Board | Pål Anders Nordvi | ||
| Board | Jan Hans Mikael Jönsson | ||
| Board | Kjell Roland Adstedt | ||
| Board | Rime Bahij | ||
| Owner (15%) | Erik Sundt | Current | |
| Owner (100%) | Real Canna Seeds Limited | ||
| Owner (100%) | Real Canna Seeds Limited | ||
| Owner (25%) | Pål Anders Nordvi | ||
| Founder | Real Canna Seeds Limited | Current |
The CEOs' other companies
Anders Raft – 1 other companies
- ANTECH INVEST A/S Active
Address history (1 moves)
| Langehede 103A, 5471 Søndersø | |
| Vejlegårdsvej 79, 2665 Vallensbæk Strand |
Former names
| Nordic Life Sciences A/S | – now |
| Real Canna Denmark A/S | – |
| Real Canna Denmark ApS | – |
Other companies at the same address
- Danex Denmark ApS Compulsorily dissolved
- Lush Therapeutics ApS Opløst
Similar companies in Nordfyns
- Lush Therapeutics ApS Søndersø
- Medical Cannabis Denmark ApS Søndersø
Questions and answers about Nordic Life Sciences A/S
Has Nordic Life Sciences A/S gone bankrupt?
No, Nordic Life Sciences A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Nordic Life Sciences A/S?
Our model estimates a bankruptcy risk of 9.4% over the next 12 months (very high risk), which is 6.7 times the average for Danish companies.
Who is the CEO of Nordic Life Sciences A/S?
Erik Sundt is the CEO of Nordic Life Sciences A/S.
Who is the auditor of Nordic Life Sciences A/S?
Nordic Life Sciences A/S most recently used Beierholm.
When was Nordic Life Sciences A/S founded?
Nordic Life Sciences A/S was founded on 24 September 2020.
What is the equity of Nordic Life Sciences A/S?
Equity was DKK -13.9m according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.